Is a complete PSTV research report available?

No complete published report is available for Plus Therapeutics, Inc. (PSTV) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Plus Therapeutics, Inc. (PSTV)

NASDAQ: PSTV · USD

$3.78

-0.04 (-1.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PSTV analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	26M
Revenue (ttm)	5.2M
Net income (ttm)	-11.9M
EPS (ttm)	-$2.62
Shares out	6.9M
Volume	63,784
Beta	1.40
Price target	$36.0	+852.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.2M
Net income (ttm): -11.9M
EPS (ttm): -$2.62
Market cap: 26M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PSTV indicators

Market & fundamental data

Available fields

214

Groups with data

Currency

USD

Showing 214 of 214 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001095981
Company name	Plus Therapeutics, Inc.
Country	United States
Country code	US
Cusip	72941H806
Employees	28
Employees Change	7%
Employees Change Percent	33.33
Enterprise value	$11.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US72941H8060
Last refreshed	2026-07-24
Market cap	$26M
Market cap category	Nano-Cap
Price	$3.78
Price currency	USD
Rev Per Employee	185,071.43x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.64
Sic	3841
Symbol	PSTV
Website	https://plustherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-46.1%
EV Sales Forward	1.29x
EV/Sales	2.22x
FCF yield	-83.94%
P/B ratio	2.19x
P/S ratio	4.99x
PS Forward	2.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-364.36%
EBITDA Margin	-356.73%
Gross margin	-83.1%
Gross Profit	$-4.3M
Net Income	$-11.9M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-230.24%
Profit Margin	-230.24%
Profit Per Employee	$-426,107
ROA	-73.82
Roa5y	-66.17
ROCE	-157.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-68.4%
Cagr15y	-63.39%
Cagr1y	-64.45%
Cagr20y	-53.79%
Cagr3y	-58.72%
Cagr5y	-66.19%
EPS Growth Quarters	1
EPS Growth Years	11
Revenue Growth	-0.46x
Revenue Growth Q	-2.93x
Revenue Growth Years	0x
Revenue Growth3 Y	92.19x
Revenue Growth5 Y	94.74x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.32
Assets	$19.9M
Cash	$15.1M
Current Assets	$18M
Current Liabilities	$8M
Debt	$725,000
Debt Equity	$0.06
Equity	$12M
Interest Coverage	-1,110.6
Liabilities	$8M
Long Term Assets	$1.9M
Long Term Liabilities	$0
Net Cash	$14.4M
Net Cash By Market Cap	$55.6
Net Cash Growth	46.42%
Net Debt Equity	$-1.2
Tangible Book Value	$11.3M
Tangible Book Value Per Share	$1.65
WACC	11.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.27
Net Working Capital	$-4.3M
Quick ratio	2.07
Working Capital	$10.1M
Working Capital Turnover	$1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1,157.41%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-100%
1Y total return	-64.42%
200-day SMA	8.88
3Y total return	-92.97%
50-day SMA	4.9
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.56%
All Time High	28,149,606.3
All Time High Change	-100%
All Time High Date	2005-12-19
All Time Low	2.9
All Time Low Change	30.34%
All Time Low Date	2026-04-07
ATR	0.31
Beta	1.4
Beta1y	2.15
Beta2y	1.4
Ch YTD	-70.49
High	3.89
High52	23.43
High52 Date	2025-10-06
High52ch	-83.86%
Low	3.72
Low52	2.9
Low52 Date	2026-04-07
Low52ch	30.35%
Ma50ch	-22.78%
Premarket Change Percent	0
Premarket Price	$3.82
Premarket Volume	123
Price vs 200-day SMA	-57.45%
RSI	37.34
RSI Monthly	30.55
RSI Weekly	34.46
Sharpe ratio	-0.19x
Sortino ratio	-0.25
Total Return	-1,157.41%
Tr YTD	-70.49
Tr15y	-100%
Tr1m	-5.03%
Tr1w	-3.08%
Tr3m	-50.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	0
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.9
Earnings Revenue Estimate	1,098,000x
Earnings Revenue Estimate Growth	-21.01x
Operating Income	$-18.9M
Operating margin	-364.4
Price target	$36
Price Target Change	$852

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,456,434%
Float Percent	93.8%
Net Borrowing	650,000
Shares Insiders	0.96%
Shares Institutions	6.28%
Shares Out	6,883,106
Shares Qo Q	20.68%
Shares Yo Y	1,157.41%
Short Float	15.65%
Short Ratio	4.79
Short Shares	14.68

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-24.1M
Average Volume	200,097.6x
Bv Per Share	1.74
CAPEX	$-882,000
Ch10y	-100
Ch15y	-100
Ch1m	-5.03
Ch1w	-3.08
Ch1y	-64.42
Ch20y	-100
Ch3m	-50.39
Ch3y	-92.97
Ch5y	-99.56
Ch6m	-46.95
Change	-1.05%
Change From Open	0.27
Close	3.82
Days Gap	-1.31
Depreciation Amortization	395,000
Dollar Volume	241,103.5
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-18.9M
EBITDA	$-18.5M
EPS	$-2.62
F Score	2
FCF	$-21.7M
FCF EV Yield	-189.05x
FCF Per Share	$-3.16
Financing CF	26,941,000
Fiscal Year End	December
Founded	1,996
Goodwill	372,000
Investing CF	-12,945,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2026-04-02
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	6.8
Ma150ch	-44.4%
Ma20	4.03
Ma20ch	-6.18%
Net CF	-6,845,000
Next Earnings Date	2026-08-13
Open	3.77
Optionable	No
Position In Range	35.29
Post Close	3.78
Postmarket Change Percent	0.53
Postmarket Price	$3.8
Ppne	1,070,000
Pre Close	3.82
Price Date	2026-07-23
Ptbv Ratio	2.29
Relative Volume	0.32x
Revenue	5,182,000x
SBC By Revenue	46.58x
Share Based Comp	2,414,000
Tr20y	-100%
Tr6m	-46.95%
Us State	Texas
Volume	63,784
Z Score	-35.72

Plus Therapeutics, Inc. (PSTV)

Coverage state: Market snapshot only — no published research

Generate the first PSTV analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · PSTV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PSTV indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PSTV

Frequently asked questions